Personalized Oncology

Frequently Asked Questions

This test offers a more targeted and personalized approach to your cancer treatment. Samples of your tumour are taken during surgery or routine biopsies and grown in the laboratory. These samples are then tested with various standard-of-care chemotherapy drugs to determine which ones would be the most effective for you. Test results can then be used by your physician as a data point to develop a more informed and individually tailored treatment strategy for your cancer#.

# Response data in the in vitro Onco-PDO® test may not always be reflective of patient-specific response due to additional physiological factors.

The test will provide an overview of how your cancer cells respond to the panel of standard chemotherapies. It ranks the therapeutic options best suited for your cancer and allows for treatment to be tailored for you, thereby increasing the likelihood of a positive response to the therapeutics prescribed.
Each individual report is specially designed to clearly present the results for your physician and aid in his or her decision-making. The test report is delivered within 2-3 weeks, allowing your physician to start you on the best regime with minimal delay.

To date, this test has been successfully done for breast, colorectal, and head and neck cancers, and is in the process of being optimized for other cancer types, such as ovarian and pancreatic. The test is intended for patients who will be undergoing chemotherapy, and is especially useful for relapsed patients who have not responded well to first line therapy.

This test has been developed in collaboration with A*STAR’s Genome Institute of Singapore, a world-leading research institution in functional genomics and integrative biology. The technology supporting the test has been published in peer-reviewed journals like Nature Communications and Nature Medicine.

Once your samples are received for testing, results are typically available in 3 weeks*.

* There is no guarantee that a tumour model can be successfully developed from the sample taken to complete the testing, due to potential sample contamination, low cell number / viability or other limitations with the sample collected.

It is best to talk to your doctor^.

^ The Onco-PDO® Testing Service is not a substitute for visits to a physician. The information in these reports should not be used independently to determine or adjust any treatment plan. Many factors besides the information covered in these reports can influence how a patient responds to a drug.

The test is performed in our laboratory in Singapore with the highest standards of laboratory practice. Tests for patients in Europe are performed in our laboratory in Munich, Germany.